Merck
CN
  • A conservative mutant of a proteolytic fragment produced during fibril formation enhances fibrillogenesis.

A conservative mutant of a proteolytic fragment produced during fibril formation enhances fibrillogenesis.

Prion (2015-01-01)
Vladimir V Egorov, Dmitry V Lebedev, Aram A Shaldzhyan, Alexey K Sirotkin, Andrey N Gorshkov, Olga A Mirgorodskaya, Natalia A Grudinina, Andrey V Vasin, Michael M Shavlovsky
ABSTRACT

The fibrillogenesis of a peptide corresponding to residues 35-51 of human α-lactalbumin (¹GYDTQAIVENNESTEYG¹⁷) can be dramatically enhanced by the addition of a tetrapeptide TDYG homologous to its C-terminus (TEYG). Generation of spontaneous hydrolytic products similar to this peptide was demonstrated by mass-spectrometry analysis of GYDTQAIVENNESTEYG peptide solution components during fibrillogenesis. Possible mechanisms and roles of short peptides in protein metabolism are discussed.

MATERIALS
Product Number
Brand
Product Description

Supelco
2,5-Dihydroxybenzoic acid, analytical standard
Supelco
2,5-Dihydroxybenzoic acid, matrix substance for MALDI-MS, ≥99.5% (HPLC), Ultra pure
Supelco
2,5-Dihydroxybenzoic acid, matrix substance for MALDI-MS, >99.0% (HPLC)
Sigma-Aldrich
2,5-Dihydroxybenzoic acid, 98%